Literature DB >> 2026270

The role of apoE in inhibitory effects of apoE-rich HDL on platelet function.

M Higashihara1, M Kinoshita, T Teramoto, S Kume, K Kurokawa.   

Abstract

Apolipoprotein E- (ApoE-) rich high-density lipoprotein (HDL), which was prepared from the bound fraction of normolipemic volunteers on heparin-Sepharose and from a hyperalphalipoproteinemic patient, potently inhibited aggregation of human platelets in a dose-dependent fashion. Dimyristoyl phosphatidylcholine liposome with apoE (apoE.DMPC) also inhibited platelet aggregation, and incubation of washed platelets with apoE.DMPC resulted in the release of cholesterol into the supernatant in a time- and dose-dependent manner. These results suggest that apoE plays a major role in the inhibitory effect of apoE-rich HDL in platelet function, presumably due to the release of cholesterol from the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026270     DOI: 10.1016/0014-5793(91)80449-d

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  Serum fibronectin 1 and ApoE levels increase with risk of lymphedema in Korean breast cancer survivors.

Authors:  Seung Yun Yim; Eunjung Ryu; Jae-Young Lim; Eun Joo Yang; Seung-Min Lee
Journal:  Support Care Cancer       Date:  2015-01-11       Impact factor: 3.603

2.  Deficiency of LRP8 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis.

Authors:  Jason O Robertson; Wei Li; Roy L Silverstein; Eric J Topol; Jonathan D Smith
Journal:  Thromb Res       Date:  2008-08-15       Impact factor: 3.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.